MarketCap
Facebook
X
TelegramCRH Medical Corporation Balance Sheet 2011-2026 | CRHM
Annual Balance Sheet CRH Medical Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
66.8 M | 61.9 M | 60 M | 49.3 M | 34.4 M | 27.4 M | 42 M | -6.6 M | -4.44 M | -2.75 M |
Long Term Debt |
70.6 M | 68.4 M | 67.6 M | 60.2 M | 38.1 M | 26.9 M | 39.5 M | - | - | - |
Total Non Current Liabilities |
74.1 M | 68.5 M | 68.8 M | 64.3 M | 54.5 M | 39.4 M | 47 M | - | - | - |
Total Current Liabilities |
11.8 M | 10.3 M | 12.9 M | 9.18 M | 12.1 M | 8.13 M | 13.2 M | 353 K | 336 K | 282 K |
Total Liabilities |
85.8 M | 78.9 M | 81.7 M | 73.5 M | 66.6 M | 47.5 M | 60.2 M | 353 K | 336 K | 282 K |
Deferred Revenue |
- | - | 26.8 K | - | - | - | 262 K | - | - | - |
Retained Earnings |
-11.9 M | 13.2 M | 12.9 M | 5.41 M | 733 K | -9.83 M | -12.9 M | -14.4 M | -16.9 M | -18.2 M |
Total Assets |
192 M | 203 M | 219 M | 198 M | 164 M | 104 M | 79 M | 8.63 M | 5.89 M | 4.1 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of CRH Medical Corporation, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Medical instruments
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
$ 20.38 | -0.8 % | $ 10.4 B | USA |
 |
Becton, Dickinson and Company
BDX
|
$ 203.39 | -0.93 % | $ 58.5 B | USA |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | USA |
 |
Harvard Bioscience
HBIO
|
$ 0.67 | -2.84 % | $ 28.4 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
$ 8.69 | -8.79 % | $ 175 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | USA |
 |
LeMaitre Vascular
LMAT
|
$ 83.44 | -0.09 % | $ 1.87 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | USA |
 |
Merit Medical Systems
MMSI
|
$ 91.18 | -2.0 % | $ 5.31 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
$ 80.74 | -1.34 % | $ 40.4 B |  Schweiz |
 |
iRhythm Technologies
IRTC
|
$ 187.58 | 1.41 % | $ 5.85 B | USA |
 |
OraSure Technologies
OSUR
|
$ 2.5 | 0.6 % | $ 186 M | USA |
 |
AtriCure
ATRC
|
$ 41.29 | -0.36 % | $ 1.94 B | USA |
 |
Repro Med Systems
KRMD
|
$ 5.69 | 1.79 % | $ 259 M | USA |
 |
electroCore
ECOR
|
$ 4.81 | -1.26 % | $ 26.5 K | USA |
 |
ICU Medical
ICUI
|
$ 150.56 | -0.15 % | $ 3.67 B | USA |
 |
AngioDynamics
ANGO
|
$ 11.02 | -3.67 % | $ 450 M | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | USA |
 |
The Cooper Companies
COO
|
$ 83.83 | -0.58 % | $ 16.7 B | USA |
 |
STERIS plc
STE
|
$ 259.25 | -0.25 % | $ 25.6 B | USA |
 |
Glaukos Corporation
GKOS
|
$ 113.49 | 0.99 % | $ 5.5 B | USA |
 |
Haemonetics Corporation
HAE
|
$ 83.15 | 0.48 % | $ 4.18 B | USA |
 |
InfuSystem Holdings
INFU
|
$ 8.93 | 1.82 % | $ 184 M | USA |
 |
Nephros
NEPH
|
$ 5.28 | -2.4 % | $ 54.8 M | USA |
 |
Masimo Corporation
MASI
|
$ 137.22 | 0.45 % | $ 7.31 B | USA |
 |
Predictive Oncology
POAI
|
$ 6.37 | -0.78 % | $ 34.7 M | USA |
 |
Intuitive Surgical
ISRG
|
$ 592.66 | -0.03 % | $ 211 B | USA |
 |
Utah Medical Products
UTMD
|
$ 57.83 | 1.03 % | $ 210 M | USA |
 |
Microbot Medical
MBOT
|
$ 2.1 | -1.41 % | $ 21.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
$ 0.28 | -2.42 % | $ 22.3 M | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
$ 22.84 | -1.64 % | $ 3.93 B | USA |
 |
Stereotaxis
STXS
|
$ 2.54 | -0.59 % | $ 205 M | USA |
 |
Pro-Dex
PDEX
|
$ 40.18 | -1.9 % | $ 132 M | USA |
 |
Pulse Biosciences
PLSE
|
$ 15.15 | 3.25 % | $ 728 M | USA |
 |
Repligen Corporation
RGEN
|
$ 168.5 | -2.18 % | $ 9.39 M | USA |
 |
ResMed
RMD
|
$ 248.48 | -0.28 % | $ 36.3 B | USA |
 |
BioLife Solutions
BLFS
|
$ 25.52 | -3.15 % | $ 1.18 B | USA |
 |
Retractable Technologies
RVP
|
$ 0.77 | 0.92 % | $ 23.1 M | USA |
 |
STAAR Surgical Company
STAA
|
$ 22.1 | -0.85 % | $ 1.09 B | USA |
 |
Teleflex Incorporated
TFX
|
$ 126.75 | 1.6 % | $ 5.94 B | USA |
 |
West Pharmaceutical Services
WST
|
$ 279.92 | -0.3 % | $ 20.4 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 12.38 | 0.04 % | $ 2.52 B | USA |